Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Axsome Therapeutics Inc (NASDAQ: AXSM) closed at $73.68 down -2.64% from its previous closing price of $75.68. In other words, the price has decreased by -$2.64 from its previous closing price. On the day, 0.9 million shares were traded. AXSM stock price reached its highest trading level at $76.56 during the session, while it also had its lowest trading level at $73.65.
Ratios:
For a deeper understanding of Axsome Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.09 and its Current Ratio is at 3.20. In the meantime, Its Debt-to-Equity ratio is 1.32 whereas as Long-Term Debt/Eq ratio is at 1.30.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on April 29, 2024, Upgraded its rating to Overweight and sets its target price to $115 from $90 previously.
On March 19, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $108.
On February 06, 2024, UBS started tracking the stock assigning a Buy rating and target price of $111.UBS initiated its Buy rating on February 06, 2024, with a $111 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 01 ’24 when Jacobson Mark L. sold 24,662 shares for $77.24 per share. The transaction valued at 1,904,942 led to the insider holds 0 shares of the business.
JEFFS ROGER sold 2,347 shares of AXSM for $168,062 on Mar 15 ’24. The Director now owns 120,756 shares after completing the transaction at $71.61 per share. On Mar 14 ’24, another insider, JEFFS ROGER, who serves as the Director of the company, sold 29,976 shares for $69.70 each. As a result, the insider received 2,089,387 and left with 120,756 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AXSM now has a Market Capitalization of 3592290560 and an Enterprise Value of 3357480448. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.94 while its Price-to-Book (P/B) ratio in mrq is 24.28. Its current Enterprise Value per Revenue stands at 13.375 whereas that against EBITDA is -13.73.
Stock Price History:
Over the past 52 weeks, AXSM has reached a high of $98.40, while it has fallen to a 52-week low of $55.02. The 50-Day Moving Average of the stock is -0.51%, while the 200-Day Moving Average is calculated to be -1.52%.
Shares Statistics:
For the past three months, AXSM has traded an average of 741.36K shares per day and 585000 over the past ten days. A total of 47.35M shares are outstanding, with a floating share count of 38.88M. Insiders hold about 18.14% of the company’s shares, while institutions hold 81.03% stake in the company. Shares short for AXSM as of 1713139200 were 7748616 with a Short Ratio of 10.45, compared to 1710460800 on 7297793. Therefore, it implies a Short% of Shares Outstanding of 7748616 and a Short% of Float of 19.620001000000002.
